AAPL325.90-0.70 (-0.21%) ▼|ABBV255.44+2.06 (+0.81%) ▲|ABT101.56-0.10 (-0.10%) ▼|ACN142.90-1.83 (-1.26%) ▼|ADBE229.06-5.68 (-2.42%) ▼|AMAT560.93+35.23 (+6.70%) ▲|AMD525.38+21.81 (+4.33%) ▲|AMGN367.54+3.37 (+0.93%) ▲|AMT164.90-2.16 (-1.29%) ▼|AMZN247.17-2.82 (-1.13%) ▼|AVGO382.16+4.00 (+1.06%) ▲|AXP351.94+0.01 (+0.00%) ▲|BA210.80+1.32 (+0.63%) ▲|BAC60.79+0.37 (+0.61%) ▲|BKNG178.79-0.66 (-0.37%) ▼|BLK1,059.56+5.45 (+0.52%) ▲|BMY60.53+0.37 (+0.62%) ▲|BNY158.42+1.49 (+0.95%) ▲|BRK-B490.08-1.17 (-0.24%) ▼|C131.93+3.21 (+2.49%) ▲|CAT881.98+17.68 (+2.05%) ▲|CL91.04-0.90 (-0.97%) ▼|CMCSA23.82+0.04 (+0.15%) ▲|COF205.51-1.26 (-0.61%) ▼|COP116.63+0.95 (+0.82%) ▲|COST930.60-5.20 (-0.56%) ▼|CRM170.78-3.01 (-1.73%) ▼|CSCO111.78+1.08 (+0.98%) ▲|CVS109.00+1.39 (+1.29%) ▲|CVX190.10+0.39 (+0.21%) ▲|DE585.12-0.89 (-0.15%) ▼|DHR175.59-25.53 (-12.69%) ▼|DIS96.29-0.12 (-0.12%) ▼|DUK125.15-0.70 (-0.56%) ▼|EMR137.79+1.21 (+0.89%) ▲|FDX314.98+8.76 (+2.86%) ▲|GD372.84+2.24 (+0.60%) ▲|GE344.68+3.38 (+0.99%) ▲|GEV1,085.71+6.53 (+0.61%) ▲|GILD132.48-0.73 (-0.55%) ▼|GM78.65+2.85 (+3.76%) ▲|GOOG348.71-2.66 (-0.76%) ▼|GOOGL349.30-2.69 (-0.76%) ▼|GS1,079.21+24.18 (+2.29%) ▲|HD329.22-3.82 (-1.15%) ▼|HON229.48+3.30 (+1.46%) ▲|IBM210.63-2.37 (-1.11%) ▼|INTC102.63+5.57 (+5.74%) ▲|INTU289.31-4.51 (-1.54%) ▼|ISRG361.07+7.90 (+2.24%) ▲|JNJ250.09+1.27 (+0.51%) ▲|JPM342.90+4.03 (+1.19%) ▲|KO81.86-0.27 (-0.32%) ▼|LIN508.76-3.29 (-0.64%) ▼|LLY1,162.73+15.83 (+1.38%) ▲|LMT504.54-5.00 (-0.98%) ▼|LOW202.62-2.09 (-1.02%) ▼|LRCX317.36+10.60 (+3.45%) ▲|MA542.28-5.16 (-0.94%) ▼|MCD264.86-2.78 (-1.04%) ▼|MDLZ59.50-0.77 (-1.28%) ▼|MDT82.86-0.43 (-0.52%) ▼|META647.09+1.24 (+0.19%) ▲|MMM174.64+15.53 (+9.76%) ▲|MO73.85-0.81 (-1.08%) ▼|MRK126.02+1.62 (+1.30%) ▲|MS215.71+4.77 (+2.26%) ▲|MSFT400.11-2.18 (-0.54%) ▼|MU924.05+58.59 (+6.77%) ▲|NEE87.87-0.13 (-0.14%) ▼|NFLX67.68+0.08 (+0.12%) ▲|NKE43.10-0.38 (-0.86%) ▼|NOW103.09-1.61 (-1.54%) ▼|NVDA205.21+1.93 (+0.95%) ▲|ORCL125.23+3.85 (+3.17%) ▲|PEP134.73-0.73 (-0.54%) ▼|PFE24.95+0.20 (+0.81%) ▲|PG147.75-1.38 (-0.93%) ▼|PLTR133.72-1.13 (-0.84%) ▼|PM191.29-1.43 (-0.74%) ▼|QCOM171.95+1.63 (+0.96%) ▲|RTX196.69+2.25 (+1.16%) ▲|SBUX104.78-0.04 (-0.03%) ▼|SCHW102.79+0.25 (+0.24%) ▲|SO93.71-0.76 (-0.80%) ▼|SPG229.40+1.21 (+0.53%) ▲|T22.01+0.06 (+0.25%) ▲|TMO519.19-7.04 (-1.34%) ▼|TMUS192.53-3.11 (-1.59%) ▼|TSLA381.19+11.62 (+3.14%) ▲|TXN291.73+7.66 (+2.69%) ▲|UBER71.95-0.23 (-0.31%) ▼|UNH432.29+10.74 (+2.55%) ▲|UNP294.88-1.37 (-0.46%) ▼|UPS115.44+2.29 (+2.02%) ▲|USB63.16+0.02 (+0.02%) ▲|V357.72-2.85 (-0.79%) ▼|VZ43.35-0.15 (-0.34%) ▼|WFC86.94+0.61 (+0.71%) ▲|WMT111.17-1.03 (-0.92%) ▼|XOM150.40+2.04 (+1.37%) ▲|AAPL325.90-0.70 (-0.21%) ▼|ABBV255.44+2.06 (+0.81%) ▲|ABT101.56-0.10 (-0.10%) ▼|ACN142.90-1.83 (-1.26%) ▼|ADBE229.06-5.68 (-2.42%) ▼|AMAT560.93+35.23 (+6.70%) ▲|AMD525.38+21.81 (+4.33%) ▲|AMGN367.54+3.37 (+0.93%) ▲|AMT164.90-2.16 (-1.29%) ▼|AMZN247.17-2.82 (-1.13%) ▼|AVGO382.16+4.00 (+1.06%) ▲|AXP351.94+0.01 (+0.00%) ▲|BA210.80+1.32 (+0.63%) ▲|BAC60.79+0.37 (+0.61%) ▲|BKNG178.79-0.66 (-0.37%) ▼|BLK1,059.56+5.45 (+0.52%) ▲|BMY60.53+0.37 (+0.62%) ▲|BNY158.42+1.49 (+0.95%) ▲|BRK-B490.08-1.17 (-0.24%) ▼|C131.93+3.21 (+2.49%) ▲|CAT881.98+17.68 (+2.05%) ▲|CL91.04-0.90 (-0.97%) ▼|CMCSA23.82+0.04 (+0.15%) ▲|COF205.51-1.26 (-0.61%) ▼|COP116.63+0.95 (+0.82%) ▲|COST930.60-5.20 (-0.56%) ▼|CRM170.78-3.01 (-1.73%) ▼|CSCO111.78+1.08 (+0.98%) ▲|CVS109.00+1.39 (+1.29%) ▲|CVX190.10+0.39 (+0.21%) ▲|DE585.12-0.89 (-0.15%) ▼|DHR175.59-25.53 (-12.69%) ▼|DIS96.29-0.12 (-0.12%) ▼|DUK125.15-0.70 (-0.56%) ▼|EMR137.79+1.21 (+0.89%) ▲|FDX314.98+8.76 (+2.86%) ▲|GD372.84+2.24 (+0.60%) ▲|GE344.68+3.38 (+0.99%) ▲|GEV1,085.71+6.53 (+0.61%) ▲|GILD132.48-0.73 (-0.55%) ▼|GM78.65+2.85 (+3.76%) ▲|GOOG348.71-2.66 (-0.76%) ▼|GOOGL349.30-2.69 (-0.76%) ▼|GS1,079.21+24.18 (+2.29%) ▲|HD329.22-3.82 (-1.15%) ▼|HON229.48+3.30 (+1.46%) ▲|IBM210.63-2.37 (-1.11%) ▼|INTC102.63+5.57 (+5.74%) ▲|INTU289.31-4.51 (-1.54%) ▼|ISRG361.07+7.90 (+2.24%) ▲|JNJ250.09+1.27 (+0.51%) ▲|JPM342.90+4.03 (+1.19%) ▲|KO81.86-0.27 (-0.32%) ▼|LIN508.76-3.29 (-0.64%) ▼|LLY1,162.73+15.83 (+1.38%) ▲|LMT504.54-5.00 (-0.98%) ▼|LOW202.62-2.09 (-1.02%) ▼|LRCX317.36+10.60 (+3.45%) ▲|MA542.28-5.16 (-0.94%) ▼|MCD264.86-2.78 (-1.04%) ▼|MDLZ59.50-0.77 (-1.28%) ▼|MDT82.86-0.43 (-0.52%) ▼|META647.09+1.24 (+0.19%) ▲|MMM174.64+15.53 (+9.76%) ▲|MO73.85-0.81 (-1.08%) ▼|MRK126.02+1.62 (+1.30%) ▲|MS215.71+4.77 (+2.26%) ▲|MSFT400.11-2.18 (-0.54%) ▼|MU924.05+58.59 (+6.77%) ▲|NEE87.87-0.13 (-0.14%) ▼|NFLX67.68+0.08 (+0.12%) ▲|NKE43.10-0.38 (-0.86%) ▼|NOW103.09-1.61 (-1.54%) ▼|NVDA205.21+1.93 (+0.95%) ▲|ORCL125.23+3.85 (+3.17%) ▲|PEP134.73-0.73 (-0.54%) ▼|PFE24.95+0.20 (+0.81%) ▲|PG147.75-1.38 (-0.93%) ▼|PLTR133.72-1.13 (-0.84%) ▼|PM191.29-1.43 (-0.74%) ▼|QCOM171.95+1.63 (+0.96%) ▲|RTX196.69+2.25 (+1.16%) ▲|SBUX104.78-0.04 (-0.03%) ▼|SCHW102.79+0.25 (+0.24%) ▲|SO93.71-0.76 (-0.80%) ▼|SPG229.40+1.21 (+0.53%) ▲|T22.01+0.06 (+0.25%) ▲|TMO519.19-7.04 (-1.34%) ▼|TMUS192.53-3.11 (-1.59%) ▼|TSLA381.19+11.62 (+3.14%) ▲|TXN291.73+7.66 (+2.69%) ▲|UBER71.95-0.23 (-0.31%) ▼|UNH432.29+10.74 (+2.55%) ▲|UNP294.88-1.37 (-0.46%) ▼|UPS115.44+2.29 (+2.02%) ▲|USB63.16+0.02 (+0.02%) ▲|V357.72-2.85 (-0.79%) ▼|VZ43.35-0.15 (-0.34%) ▼|WFC86.94+0.61 (+0.71%) ▲|WMT111.17-1.03 (-0.92%) ▼|XOM150.40+2.04 (+1.37%) ▲|
24.8 C
New York
Tuesday, July 21, 2026

Tag: Navarro

newssourceFORcompanyinformationcontent1releasesmarket

Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, held today its shareholders general meeting at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.

Résultats de l’Assemblée Générale Mixte de Cellectis du 25 juin 2026

NEW YORK, 25 juin 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome pour développer des thérapies cellulaires et géniques, a tenu son assemblée générale mixte ce jour à 14h30, heure de Paris, à l’auditorium du site Biopark, situé au 11 rue Watt, 4ème étage, 75013 Paris, France.

GWM TANK 700 Hi4-T gana 11 de 13 etapas en el Rally Taklimakan 2026

URUMQI, China y XINJIANG, China, June 12, 2026 (GLOBE NEWSWIRE) -- Cuando concluyó el Rally Taklimakan 2026 el 1 de junio, GWM había hecho mucho más que simplemente finalizar el finalizar el Rally Taklimakan 2026. Arrasó con todos los títulos de la categoría T2 de producción: La T2.E Copa de Fabricantes de Nueva Energía, la T2.1 Copa de Fabricantes de Combustible y la T2.3 Copa de Clubes de Producción.

GWM TANK 700 Hi4-T Wins 11 of 13 Stages at 2026 Taklimakan Rally

GWM TANK 700 Hi4-T Wins 11 of 13 Stages at 2026 Taklimakan Rally

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to lasmecabtagene timgedleucel (lasme-cel), its CD22-targeting allogeneic CAR-T cell therapy product candidate, for the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL).

Jalisco, Mexico Takes Center Stage as Host of the 2026 MICHELIN Guide Ceremony, Showcasing 13 Newly Recognized Restaurants

GUADALAJARA, Mexico, June 5, 2026 /PRNewswire-HISPANIC PR WIRE/ -- Jalisco, Mexico has firmly established itself on the global culinary stage as the official host...

Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure

STANLEY 1913 BRAND AND MESSI BRANDS RETURN: NEW STRIKER BLUE COLLECTION CELEBRATES MESSI’S ARGENTINIAN ROOTS & PEAK PERFORMANCE

The bold new collection blends precision design with cultural storytelling and superior hydration – inviting fans and athletes to participate in and celebrate Messi's...

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

PARIS, 04 juill. 2025 (GLOBE NEWSWIRE) --

(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)

Monthly information on share capital and company voting rights

PARIS, July 04, 2025 (GLOBE NEWSWIRE) --

(Article 223-16 of General Regulation of the French financial markets authority)

Solera und AkzoNobel schließen Partnerschaft zur Förderung datengestützter Nachhaltigkeit in der Fahrzeugreparatur

Die strategische Partnerschaft ermöglicht Karosseriewerkstätten und Versicherern, die CO₂-Emissionen pro Reparaturvorgang auf Basis prozessspezifischer Lack- und Energiedaten präzise zu berechnen 
Die strategische Partnerschaft ermöglicht Karosseriewerkstätten und Versicherern, die CO₂-Emissionen pro Reparaturvorgang auf Basis prozessspezifischer Lack- und Energiedaten präzise zu berechnen

MSP Recovery Law Firm Files Class Action Lawsuit Against Ralph Navarro and FYI Yachts for Alleged Fraud, Racketeering, and Consumer Abuse

CLASS ACTION LAWSUIT FILED AGAINST RALPH NAVARRO AND FYI YACHTS FOR FRAUD, RACKETEERING, AND CONSUMER ABUSE

Trump’s Team: Tariffs Are Harmless, Trust Us—Court’s Laughter Ensues

In the latest episode of "Tariff Theatre," President Trump's controversial tariffs have been declared illegal by a federal trade court. But fear not, Howard...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNavarro

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers